This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n6http://linked.opendata.cz/resource/drugbank/drug/DB07148/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07148/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n8http://linked.opendata.cz/resource/drugbank/property/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07148/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07148/identifier/pubchem-substance/

Statements

Subject Item
n2:DB07148
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n4:DB07148 n13:DB07148
dcterms:title
(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one
adms:identifier
n6:DB07148 n9:99443619 n10:552 n11:46937054
n7:IUPAC-Name
n8:271B4EAB-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B4EB1-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B4EB0-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B4EAD-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B4EAE-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B4EAF-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B4EA9-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B4EAA-363D-11E5-9242-09173F13E4C5 n8:271B4EA7-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B4EA8-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B4EB7-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B4EB8-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B4EB2-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B4EB3-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B4EB5-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B4EB4-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B4EB6-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B4EBD-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B4EBF-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B4EC0-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B4EBC-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B4EBB-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B4EBE-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B4EAC-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B4EB9-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B4EBA-363D-11E5-9242-09173F13E4C5